Organizations Filed Purposes:
The Foundation's primary purpose is to advance the mission of the Food and Drug Administration to modernize medical, veterinary, food, food ingredient, and cosmetic product development, accelerate innovation, and enhance product safety pursuant to Section 770 of the Federal Food, Drug, and Cosmetic Act.
The Foundation's primary purpose is to support the scientific mission of the U.S. Food and Drug Administration by advancing regulatory science and research to modernize medical, veterinary, food, food ingredient and cosmetic product development, accelerate innovation and enhance product safety pursuant to Section 770 of the Federal Food, Drug and Cosmetic Act. The Foundation provides a unique opportunity to bring all parties to the table to work together to create new science.
Innovation in Medical Evidence Development and Surveillance (IMEDS) - The Reagan-Udall Foundation has formed a public-private partnership to provide access for private-sector entities, such as regulated industry, academic institutions, and non-profit organizations, to a system based on the Food and Drug Administration's (FDA) Sentinel Initiative.
Expanded Access Navigator Program - EA - also known as compassionate use, named-patient use, or single-patient access - provides some patients who have serious or life-threatening diseases or conditions with access to investigational treatments not approved by the U.S. Food and Drug Administration. The Reagan-Udall Foundation's Expanded Access Navigator provides physicians, patients, and caregivers with guidance on EA and related topics.
Big Data for Patients Project - A project funded by the Patient-Centered Outcomes Research Institute (PCORI) that helps train and educate patient advocates on issues related to the use of big data in biomedical research.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| June S Wasser Ma | Executive Director | 40 | $220,142 |
| Amar Bhat Phd | Chief Operating Officer | 40 | $172,716 |
| Lea Ann Mcnee Ma | Director of Communications and Engagement | 40 | $144,453 |
| David Woodbury Mba | Director of Operations | 40 | $137,753 |
| Carla Rodriguex-Watson Phd | IMEDS Scientific Director | 40 | $130,367 |
| Lynne Zydowsky Phd | Director | 4 | $0 |
| Diana Zuckerman Phd | Director | 4 | $0 |
| Andrew Von Eschenbach Md | Director | 4 | $0 |
| Mark Mcclellan Md Phd | Director | 4 | $0 |
| Garry Neil Md | Director | 4 | $0 |
| Sally Greenberg Jd | Director | 4 | $0 |
| Helen Darling Ma | Director | 4 | $0 |
| Allan Coukell Bscpharm | Director | 4 | $0 |
| Georges Benjamin Md | Director | 4 | $0 |
| Ed Allera Jd | Director | 4 | $0 |
| Kay Holcombe Ms | Secretary | 4 | $0 |
| Jonathan Leff Mba | Chair, Finance Committee | 4 | $0 |
| Richard Schilsky Md | Vice Chair | 4 | $0 |
| Ellen Sigal Phd | Chair | 4 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202002689349301210_public.xml